MannKind Corp
MNKD
#5812
Rank
NZ$2.24 B
Marketcap
NZ$6.97
Share price
3.72%
Change (1 day)
-27.60%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2023 (TTM): NZ-$0.31

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is NZ-$0.23. In 2022 the company made an earnings per share (EPS) of NZ-$0.61 a decrease over its 2021 EPS that were of NZ-$0.57.

EPS history for MannKind Corp from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$0.31-48.49%
2022NZ-$0.616.25%
2021NZ-$0.5728%
2020NZ-$0.45-7.41%
2019NZ-$0.48-55.74%
2018NZ-$1.09-45.05%
2017NZ-$1.98-188.1%
2016NZ$2.25-128.31%
2015NZ-$7.9674.51%
2014NZ-$4.56-20.31%
2013NZ-$5.72-32.63%
2012NZ-$8.49-28.03%
2011NZ-$11.80-12%
2010NZ-$13.41-27.54%
2009NZ-$18.51-30.3%
2008NZ-$26.55-18.85%
2007NZ-$32.72-19.03%
2006NZ-$40.4156.94%
2005NZ-$25.75-21.74%
2004NZ-$32.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.36-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$7.29-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$55.19-23,843.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.78-863.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$6.29-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$5.29 2,176.92%๐Ÿ‡บ๐Ÿ‡ธ USA